3.8 Article

Microencapsulated conjugated linoleic acid associated with hypocaloric diet reduces body fat in sedentary women with metabolic syndrome

期刊

VASCULAR HEALTH AND RISK MANAGEMENT
卷 8, 期 -, 页码 661-667

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/VHRM.S37385

关键词

conjugated linoleic acid; metabolic syndrome; body composition; cardiovascular disease

资金

  1. Carlos Chagas Filho Foundation

向作者/读者索取更多资源

Background: Animal studies have suggested beneficial effects of conjugated linoleic acid (CLA) in reducing body fat mass and improvement in the serum lipid profile and glycemia. However, these effects are controversial in humans. The purpose of this study was to investigate the effects of microencapsulated CLA supplementation on body composition, body mass index, waist circumference, and blood pressure in sedentary women with metabolic syndrome. Methods: This study was a placebo-controlled and randomized clinical trial. Fourteen women diagnosed with metabolic syndrome received light strawberry jam enriched or not with microencapsulated CLA (3 g/day) as a mixture of 38.57% cis-9, trans-11, and 39.76% trans-10, cis-12 CLA isomers associated with a hypocaloric diet for 90 days. The subjects were monitored to assess variables associated with the metabolic syndrome, in addition to assessing adherence with the intervention. Results: There were no significant effects of microencapsulated CLA on the lipid profile or blood pressure. Mean plasma insulin concentrations were significantly lower in women supplemented with microencapsulated CLA (Delta T-90 - T-0 = -12.87 +/- 4.26 mu U/mL, P = 0.02). Microencapsulated CLA supplementation did not alter the waist circumference, but there was a reduction in body fat mass detected after 30 days (Delta = -2.68% +/- 0.82%, P = 0.02), which was maintained until the 90-day intervention period (Delta = -3.32% +/- 1.41%, P = 0.02) in the microencapsulated CLA group. The placebo group showed this effect only after 90 days (Delta = -1.97% +/- 0.60%, P = 0.02), but had a reduced waist circumference (Delta T-90 - T-0 = -4.25 +/- 1.31 cm, P = 0.03). Conclusion: Supplementation with mixed-isomer microencapsulated CLA may have a favorable effect on glycemic control and body fat mass loss at an earlier time in sedentary women with metabolic syndrome, although there were no effects on lipid profile and blood pressure.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据